Forsta AP Fonden Grows Position in HCA Healthcare, Inc. (NYSE:HCA)

Forsta AP Fonden lifted its stake in HCA Healthcare, Inc. (NYSE:HCA) by 0.4% during the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 54,700 shares of the company’s stock after buying an additional 200 shares during the quarter. Forsta AP Fonden’s holdings in HCA Healthcare were worth $18,902,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Cheviot Value Management LLC bought a new stake in HCA Healthcare in the first quarter worth $26,000. Atwood & Palmer Inc. bought a new position in HCA Healthcare during the first quarter valued at $28,000. Bartlett & CO. Wealth Management LLC increased its position in HCA Healthcare by 888.9% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company’s stock valued at $31,000 after acquiring an additional 80 shares during the last quarter. ORG Partners LLC increased its position in HCA Healthcare by 344.0% during the first quarter. ORG Partners LLC now owns 111 shares of the company’s stock valued at $38,000 after acquiring an additional 86 shares during the last quarter. Finally, Migdal Insurance & Financial Holdings Ltd. increased its position in HCA Healthcare by 75.8% during the first quarter. Migdal Insurance & Financial Holdings Ltd. now owns 116 shares of the company’s stock valued at $40,000 after acquiring an additional 50 shares during the last quarter. Institutional investors own 62.73% of the company’s stock.

Insider Activity at HCA Healthcare

In other HCA Healthcare news, COO Jon M. Foster sold 15,698 shares of the firm’s stock in a transaction that occurred on Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the completion of the transaction, the chief operating officer directly owned 12,646 shares of the company’s stock, valued at approximately $4,670,420.72. This trade represents a 55.38% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 1.30% of the stock is owned by insiders.

HCA Healthcare Stock Performance

HCA stock opened at $381.84 on Friday. The firm has a market cap of $89.35 billion, a price-to-earnings ratio of 16.05, a PEG ratio of 1.17 and a beta of 1.39. The firm has a 50-day simple moving average of $369.74 and a two-hundred day simple moving average of $349.15. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $417.14. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.86 and a current ratio of 0.98.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, July 25th. The company reported $6.84 EPS for the quarter, beating the consensus estimate of $6.20 by $0.64. The firm had revenue of $18.61 billion during the quarter, compared to analyst estimates of $18.49 billion. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. HCA Healthcare’s revenue was up 6.4% on a year-over-year basis. During the same period last year, the firm posted $5.50 EPS. On average, equities analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th will be given a $0.72 dividend. This represents a $2.88 annualized dividend and a dividend yield of 0.8%. The ex-dividend date of this dividend is Tuesday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is presently 12.11%.

Analyst Ratings Changes

HCA has been the topic of a number of analyst reports. Barclays cut their price objective on shares of HCA Healthcare from $416.00 to $390.00 and set an “overweight” rating on the stock in a research report on Monday, July 28th. Baird R W cut shares of HCA Healthcare from a “strong-buy” rating to a “hold” rating in a report on Tuesday, April 15th. Wells Fargo & Company raised shares of HCA Healthcare from an “underweight” rating to an “equal weight” rating and lifted their price target for the company from $320.00 to $385.00 in a research note on Thursday, May 29th. Wolfe Research downgraded shares of HCA Healthcare from an “outperform” rating to a “peer perform” rating in a research note on Monday, July 28th. Finally, JPMorgan Chase & Co. lifted their price target on shares of HCA Healthcare from $360.00 to $370.00 and gave the company a “neutral” rating in a research note on Monday, August 4th. Nine analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $395.69.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.